Across TCGA pan-cancer cohorts, MIR3976HG RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR3976HG data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR3976HG RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3976HG expression acts as an unfavorable survival marker, although some lineages such as PAAD and STAD show a favorable association.
UCS, KIRP, and KIRC are the cancer types where MIR3976HG RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.